Emergency Medicine Reports - April 1, 2007

Target Audience:

This continuing medical education activity is intended for emergency physicians.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.3 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editors
J. Stephan Stapczynski, MD
Chair
Emergency Medicine Department
Maricopa Medical Center
Phoenix, Arizona

Sandra M. Schneider, MD
Professor and Chair
Department of Emergency Medicine
University of Rochester School of Medicine
Rochester, New York

CME Question Reviewer
Roger Farel, MD
Retired
Newport Beach, CA

Author
Thomas B. Perera, MD
Assistant Professor
Department of Emergency Medicine
Jacobi/Montefiori Medical Center
Bronx, NY

Co-Author
Jesse Carron, MD
Department of Emergency Medicine
Jacobi/Montefiori Medical Center
Bronx, NY

Peer Reviewers
David Overton, MD, MBA, FACEP, FACP
Emergency Medicine Program Director
Michigan State University
Kalamazoo Center for Medical Studies
Professor and Chairman of Emergency Medicine
Michigan State University College of Human Medicine

Keith Grams, MD
Associate Medical Director
Assistant Professor
Clinical Emergency Medicine
Department of Emergency Medicine
Strong Memorial Hospital
Rochester, NY

Subjects:

  • Upper Gastrointestinal Bleeding

Objectives:

  • quickly recognize or increase index of suspicion for specific conditions
  • understand the epidemiology, etiology, pathophysiology, and clinical features of the entity discussed
  • apply state-of-the-art diagnostic and therapeutic techniques (including the implications of pharmaceutical therapy discussed) to patients with the particular medical problems discussed
  • understand the differential diagnosis of the entity discussed
  • understand both likely and rare complications that may occur

Financial Disclosure:

To reveal any potential bias in this publication, and in accordance with Accreditation Council for Continuing Medical Education guidelines, we disclose that J. Stephan Stapczynski, MD (editor) served as a consultant to Pfizer on the drugs linezolid and dalbavancin. Roger Farel, MD (CME question reviewer) owns stock in Johnson & Johnson. Sandra M. Schneider, MD (editor), Thomas B. Perera, MD (author), Jesse Carron, MD (co-author), David Overton, MD, MBA, FACEP, FACP (peer reviewer), and Keith Grams, MD (peer reviewer) report no relationships with companies related to the field of study covered by this CME activity.

Copyright 2007 AHC Media. All rights reserved.